News Medical on MSN1 个月
Calluna Pharma successfully completes Phase 1 clinical study of CAL101, a first-in-class ...
Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat ...
来自MSN11 个月
Newly launched Calluna raises $81m to advance monoclonal antibody pipeline
European biotechs Oxitope Pharma and Arxx Therapeutics have merged to form Calluna Pharma, raising €75m ($81m) in a Series A funding round. Led by existing lead investors Forbion, Sarsia ...